Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
EG-009 by Shenzhen Evergreen Therapeutics for Coronavirus Disease 2019 (COVID-19) Associated Cytokine Release Syndrome: Likelihood of Approval
EG-009 is under clinical development by Shenzhen Evergreen Therapeutics and currently in Phase I for Coronavirus Disease 2019 (COVID-19) Associated...